ArticleWorld journal of gastrointestinal endoscopy2026
Low-volume bowel preparation provides safe and effective pan-enteric capsule endoscopy in suspected or established Crohn's disease.
Article in World journal of gastrointestinal endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEffective pan-enteric capsule endoscopy (PCE) visualization requires thorough bowel preparation. We hypothesized that a novel low-volume protocol (LVP) provides comparable safety and effectiveness to the standard high-volume protocol (HVP).
aimTo evaluate the safety and effectiveness of a novel low-volume
methodsWe conducted an observational study including all prospectively documented PCEs at our tertiary center (2018-2021), comparing preparation adequacy and completion rates between patients receiving LVP
resultsOur analysis included 67 patients: 12 (17.9%) underwent PCE with HVP, and 55 (82.1%) with LVP. No post-PCE complications were reported. PCE completion was achieved by 89.1% of the LVP group and 75.0% of the HVP group. Adequate small bowel and colonic preparation rates were comparable between the HVP and LVP groups (90.9%
conclusionLVP is a safe and effective alternative to HVP with similar completion rates, better colonic preparation, and lower volume, making it preferable for patients with suspected or diagnosed Crohn's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.